Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sapphire Bioscience Holding ApS
APS
Active
Advertising protection
CVR 38599917
Industriparken 39, 2750
Ballerup
Activities of holding companies
·
NACE 6421
Est. 2017 · 9 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Sapphire Bioscience Holding ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MK
Michel Krall Jürgens
Management
Management
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
TT
Thais Taaning Johansen
Board of Directors
Board of Directors
2017
PM
Peter Max
Board of Directors
Board of Directors
2017
HH
Harald Høegh
Chairman
Chairman
2025
EL
Eirik Lauglo
Board of Directors
Board of Directors
2021
GP
Gustaf Peter Reinhold von Ehrenheim
Board of Directors
Board of Directors
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Vind Industry AS
Individual
66.67–89.99%
66.67–89.99%
2022
TTJ Invest Holding ApS
Company
25–33.32%
25–33.32%
2021
Farsjundet Industri AB
Individual
10–14.99%
10–14.99%
2017
GINSBORG HOLDING ApS
Company
5–9.99%
5–9.99%
2017
RMP HOLDING ApS
Company
5–9.99%
5–9.99%
2017
CAIXA INVEST ApS
Company
5–9.99%
5–9.99%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Sapphire Bioscience Holding ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network